Gilead Sciences, Inc. (GILD) Tops Q3 EPS by 1c, Sales Fall Inline
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $151.37 -0.85%
EPS Growth %: -14.2%
Financial Fact:
Interest and other income, net: 119M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -14.2%
Financial Fact:
Interest and other income, net: 119M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q3 EPS of $1.02, $0.01 better than the analyst estimate of $1.01. Revenue for the quarter came in at $2.12 billion versus the consensus estimate of $2.11 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- Ennis (EBF) Misses Q2 EPS by 2c
- Gilead expands lenacapavir licensing to cover once-yearly HIV prevention
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
